The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
Dr Shoaib Ugradar Discusses Teprotumumab for Thyroid Eye Disease and Data Collected
March 21st 2022Teprotumumab has shown great efficacy in treating thyroid eye disease in both clinical trials and real-world settings, but more data are needed on adverse events, said Shoaib Ugradar, MD, UCLA Stein Eye Center Santa Monica.
Read More
Selective Laser Trabeculoplasty Use in Glaucoma
A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option.
Read More
Darren Chen: Overall, Patients Were Satisfied With Ophthalmic Video Visits
March 14th 2022A majority of patients with ophthalmic video visits were satisfied, but there were some predictors that contributed to which patients were more satisfied, explained Darren Chen, MD student at Weill Cornell Graduate School of Medical Sciences.
Read More
Novel Therapy in Glaucoma: Sustained Delivery Implants
A review of the novel sustained release approach with bimatoprost implants and how this is affecting glaucoma management.
Read More
Dr Robert Fante: More Data Will Provide More Insight Into Use of Teprotumumab for TED
March 7th 2022As more data are gathered on teprotumumab for use in thyroid eye disease (TED), we’ll have a better understanding of which subgroups respond better or worse to the treatment, explained Robert G. Fante, MD, FACS, president of the American Society of Ophthalmic Plastic & Reconstructive Surgery and facial plastic surgeon and cosmetic surgeon, Fante Eye & Face Centre in Denver, Colorado.
Read More
Addressing Patient Adherence in Glaucoma Management
Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens.
Read More
Glaucoma: Utilization Management and Patient Access to Therapy
Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy.
Read More
Dr James Auran Outlines How to Address Shortages of Ophthalmic Trauma Care Providers
February 18th 2022James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, lists potential solutions to bolster ophthalmic trauma care in the United States.
Read More
Xipere for Macular Edema Associated With Uveitis Launches in United States
February 16th 2022The treatment was approved in October 2021 and is the first FDA-approved therapy to treat macular edema associated with uveitis via injection to the suprachoroidal space, which provides a more targeted delivery mechanism.
Read More
The Importance of Vision Preservation in Patients With Glaucoma
A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.
Read More
Dr Anne Barmettler Discusses Potential Adverse Events Associated With Teprotumumab
February 7th 2022Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center, outlines adverse events patients taking teprotumumab for thyroid eye disease may experience.
Read More
Dr Leon Herndon on Tailoring Glaucoma Care for Older Patients
February 3rd 2022Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains how older patients with glaucoma may lose nerve fiber layer at a quicker rate than younger patients.
Read More